CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer
Ruixin Sun(Hebei Agricultural University), Zonghai Li(Guizhou Normal University)
Cited by 80
Related Papers
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
|Molecular Therapy|2017|184
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
|Cancer Immunology Immunotherapy|2018|63